GlassScriptPhysician profile
Maureen P Utz
NPI 1609851229
$485.98
in general payments reported to CMS, 2019-2025
16 companies · $9.93 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.02 · 2020: $45.00 · 2021: $147 · 2022: $135 · 2023: $27.94 · 2024: $64.33 · 2025: $9.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $78.92 | 2021-2024 | Taltz |
| Incyte Corporation | $67.24 | 2021-2024 | Opzelura |
| Ucb, INC. | $61.94 | 2021-2024 | Bimzelx |
| Tactile Systems Technology INC | $60.00 | 2021 | |
| Amgen INC. | $60.00 | 2020-2021 | |
| Janssen Biotech, INC. | $33.58 | 2022 | |
| Genzyme Corporation | $16.61 | 2021 | |
| Mallinckrodt Enterprises LLC | $16.59 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $15.09 | 2024 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $13.20 | 2023 | |
| Pfizer INC. | $12.45 | 2022 | |
| Sun Pharmaceutical Industries INC. | $12.14 | 2019 | |
| Abbvie INC. | $11.26 | 2019 | |
| Dermira, INC. | $10.91 | 2019 | |
| Organon LLC | $9.93 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pierre Fabre Pharmaceuticals, INC. | $6.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maureen Utz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.